All about 2024 Saxenda lawsuit: Liraglutide has been approved since 2010 for use in the treatment of diabetes under the brand name Victoza. Victoza has already been tagged as a potential cause of pancreatic cancer. According to reports published by the FDA, Victoza was a suspected cause of more than 300 deaths and over 3,000 hospital visits between 2010 and 2014. Around one-third of those fatalities were the result of pancreatic cancer. Hundreds of Victoza lawsuits have already been filed. It makes sense Victoza would go first because it is an older drug. But, if you believe the science that plaintiffs’ lawyers tried to adopt, Saxenda could cause a greater cancer risk because it contains a much higher dose of Liraglutide than Victoza. This drove interest in Saxenda cancer lawsuits. But conclusive scientific proof did not follow. Find additional information on Saxenda lawsuit.
While previous studies found a link between diabetics who take Glucagon-like peptide-1 receptor agonists and an increased risk of gastrointestinal side effects, another study examined the risks of people taking GLP-1 agonists strictly for weight loss such as Saxenda. The study included 613 patients taking Wegovy, Ozempic and Rybelsus and 4,144 taking Saxenda and compared them to 654 patients on bupropion-naltrexone (Contrave), a popular weight loss medication that is not a GLP-1 drug. The study also found that 11 of the patients on semaglutide and 372 patients on liraglutide faced gastrointestinal problems, compared to only 22 patients on bupropion-naltrexone.
The study found that, compared to patients on Contrave, patients taking the two GLP-1 agonists, including Saxenda, had a 9.09 times greater risk of pancreatitis, 4.22 times greater risk of bowel obstruction, and a 3.67 times greater risk of gastroparesis, or stomach paralysis. Moreover, CNN recently reported that at least two people taking drugs in the same class as Saxenda, one taking Ozempic and the other taking Wegovy, have experienced more than just minor stomach issues; these individuals have been diagnosed with gastroparesis, or “paralyzed stomachs.”
A resident of Kentucky has initiated a lawsuit against Novo Nordisk A/S and its subsidiaries, accusing the company of failing to warn about the potential risk of permanent stomach paralysis caused by its weight loss medication, Saxenda (liraglutide). The plaintiff consumed Saxenda from March 2019 to April 2021 and is now experiencing gastroparesis, which has resulted in severe consequences such as persistent vomiting and abdominal pain, requiring multiple visits to the hospital. The lawsuit alleges that since the drug’s approval by the FDA in 2014, Novo Nordisk has promoted Saxenda as a weight loss solution without adequately disclosing the potential for gastrointestinal disorders, despite clinical trials indicating such risks.
The exact mechanism by which Saxenda may contribute to the development of gastroparesis is not yet fully understood. However, it is thought that the medication may affect the nerves and muscles in the stomach, leading to a disruption in gastric motility. This can result in the delayed emptying of food from the stomach, causing the symptoms associated with gastroparesis. It normally takes around six to eight hours for food to pass from the stomach to the small intestine. With gastroparesis, however. the digestion process is extended with the amount of extension differing from person to person. One study which was published in the Lancet Gastroenterology and Hepatology observed how liraglutide affected digestion. The participants in the study took either liraglutide or a placebo for five weeks and then ate a meal containing a radioactive tracer which allowed researchers to see how long the food stayed in their stomachs.
These Saxenda side effects can range from mild impairment of kidney function to severe kidney damage. It is important for patients taking Saxenda to be aware of the potential risk and to closely monitor their kidney function through regular blood tests with their physician. Saxenda and Gallbladder Disease – One of the more concerning side effects of Saxenda is its potential connection to gallbladder disease. The gallbladder is a small organ located beneath the liver, responsible for storing bile, a substance that aids in the digestion of fats. Studies have shown that Saxenda can increase the risk of gallbladder-related problems, such as gallstones and inflammation. Gallstones are solid deposits that form in the gallbladder, often causing pain and discomfort. In severe cases, gallstones can lead to more serious conditions, such as cholecystitis or pancreatitis.
Is There a Cure for Gastroparesis? According to the Mayo Clinic, there is no known cure for gastroparesis, although withdrawal of the drug may bring an end to it. Gastroparesis can cause major complications in the body, like dehydration, malnutrition, and a decreased quality of life. Has Saxenda been Recalled? No, despite the increase in reported serious Saxenda side effects and the corresponding increase in Saxenda lawsuits, the FDA has not recalled Saxenda. Will I Suffer Withdrawal Symptoms if I Stop Taking Saxenda ? Saxenda is not an addictive or habit-forming medication, and therefore you will not get withdrawal symptoms when you finish your treatment. However, you could develop a pattern of binge eating, blood sugar spike and weight gain which can cause anxiety and other health problems. If you are thinking of stopping Saxenda treatment it is best to talk to you doctor prior to suddenly stopping.
While the evidence is still inconclusive, some studies have suggested a potential link between the use of Saxenda and an increased risk of thyroid cancer. Furthermore, in rare cases, individuals taking Saxenda may experience severe allergic reactions, which can be life-threatening if not treated promptly.
If you took Saxenda and developed gallbladder disease, Saxenda stomach paralysis, or any other serious Saxenda side effects, contact Timothy L. Miles, a Sazenda lawyer in Nashville, today. ?You may be eligible for a Saxenda Lawsuit ?and possibly may be entitled to substantial compensation. See additional information on https://www.masstortsheadquarters.com/saxenda-lawsuit.html/.
?Timothy L. Miles is a plaintiff’s lawyer in Nashville, Tennessee, and a nationally known top-rated class action and product liability lawyer who has been leading the fight to protect the rights of injured victims for over 20 years.
Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for injured victims, consumers, and shareholders, shaped precedent-setting decisions, and delivered real reforms. Judges and peers have repeatedly recognized Mr. Miles’ relentless advocacy for the underdog, as well as his unbendable ethical standards.